首页> 外文期刊>European journal of human genetics: EJHG >The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics
【24h】

The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics

机译:LRRK2-G2019S突变:开启帕金森氏病遗传学的新纪元

获取原文
获取原文并翻译 | 示例
           

摘要

The role of genetic factors in the etiology of Parkinson's disease (PD) has long been considered negligible, but a series of recent discoveries are dramatically changing this view. Two studies recently published in The New England Journal of Medicine report an astonishing high prevalence of a single mutation in leucine-rich repeat kinase 2 (LRRK2), G2019S, in North African Arabs and Ashkenazi Jews with PD.Mutations in the LRRK2 gene were first identified in 2004 in families with autosomal-dominant PD;soon thereafter, the G2019S mutation (c.G6055A) was identified by several groups as a common cause of this disease, being found not only in approx 5-6% of familial PD but also in approx 1-2%of sporadic PD in several European and US populations.
机译:长期以来,人们一直认为遗传因素在帕金森氏病(PD)病因学中的作用可以忽略不计,但是最近的一系列发现极大地改变了这一观点。最近发表在《新英格兰医学杂志》上的两项研究报道了在北非阿拉伯人和患有PD的犹太人中,富含亮氨酸的重复激酶2(LRRK2),G2019S的单个突变的惊人流行率很高。首先是LRRK2基因的突变。于2004年在常染色体显性遗传PD家族中被发现;此后不久,G2019S突变(c.G6055A)被几组人确定为该病的常见病因,不仅在家族性PD的约5-6%中被发现在欧洲和美国的一些人群中,约占散发性PD的1-2%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号